The estimated Net Worth of Daniel H Petree is at least $217 Thousand dollars as of 8 February 2022. Mr. Petree owns over 14,277 units of Sutro Biopharma Inc stock worth over $102,642 and over the last 6 years he sold STRO stock worth over $0. In addition, he makes $114,180 as Director at Sutro Biopharma Inc.
Daniel has made over 5 trades of the Sutro Biopharma Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 14,277 units of STRO stock worth $72,527 on 8 February 2022.
The largest trade he's ever made was exercising 14,277 units of Sutro Biopharma Inc stock on 8 February 2022 worth over $72,527. On average, Daniel trades about 1,737 units every 94 days since 2018. As of 8 February 2022 he still owns at least 22,265 units of Sutro Biopharma Inc stock.
You can see the complete history of Mr. Petree stock trades at the bottom of the page.
Daniel H. Petree is a Director of the Company. In April 2012, Mr. Petree co-founded Four Oaks Partners Consulting, LLC, which provides transaction advisory services to small and medium-sized life science companies and in 2000, Mr. Petree co-founded P2 Partners, LLC, Four Oaks’ predecessor in the same business. Before co-founding P2 Partners, Mr. Petree served as President and Chief Operating Officer of Axys Pharmaceuticals, Inc., Executive Vice President and Chief Financial Officer of Arris Pharmaceuticals, Incorporated and Vice President of Business Development at TSI Corporation and was a corporate and securities lawyer. Mr. Petree previously served on the boards of directors of Lpath, Inc., Biocept, Inc. and Cypress Bioscience, Inc. along with a number of privately held biotechnology companies. Mr. Petree received an A.B. in History and Political Science from Stanford University and a J.D. from the University of Michigan Law School.
As the Director of Sutro Biopharma Inc, the total compensation of Daniel Petree at Sutro Biopharma Inc is $114,180. There are 13 executives at Sutro Biopharma Inc getting paid more, with William Newell having the highest compensation of $3,817,120.
Daniel Petree is 64, he's been the Director of Sutro Biopharma Inc since 2009. There are 5 older and 15 younger executives at Sutro Biopharma Inc. The oldest executive at Sutro Biopharma Inc is Dr. Shabbir T. Anik, 68, who is the Chief Technical Operations Officer.
Daniel's mailing address filed with the SEC is C/O SUTRO BIOPHARMA, INC., 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Over the last 6 years, insiders at Sutro Biopharma Inc have traded over $14,451,171 worth of Sutro Biopharma Inc stock and bought 750,858 units worth $10,652,478 . The most active insiders traders include Corp /De/ Celgene, John Gordon Freund, and Daniel Janney. On average, Sutro Biopharma Inc executives and independent directors trade stock every 19 days with the average trade being worth of $129,762. The most recent stock trade was executed by Jane Chung on 9 August 2024, trading 18,750 units of STRO stock currently worth $86,438.
at sutro biopharma we have pioneered a compelling and unique way of discovering, developing and manufacturing therapeutics. our focus is aimed primarily on next generation cancer therapeutics — antibody conjugates and bispecific antibodies. unconstrained by traditional methods of cell-based discovery, we can design and develop targeted medicines by innovating outside the constraints of the cell. our technology enables us to iteratively discover and test molecules in a rapid cycle of weeks rather than months, to rapidly identify the optimal molecule designed for safety and potency. our approach to discovery, without the cell, is also transcending the the limitations of biologics manufacturing. sutro has the world’s only cgmp cell-free manufacturing facility located in san carlos, california. this state-of- the-art facility confers an important competitive advantage as we head into human clinical trials in 2018. in addition to developing our own oncology pipeline, sutro biopharma is coll
Sutro Biopharma Inc executives and other stock owners filed with the SEC include: